PHGDH heterogeneity potentiates cancer cell dissemination and metastasis.
Rossi M, Altea-Manzano P, Demicco M, Doglioni G, Bornes L, Fukano M, Vandekeere A, Cuadros AM, Fernández-García J, Riera-Domingo C, Jauset C, Planque M, Alkan HF, Nittner D, Zuo D, Broadfield LA, Parik S, Pane AA, Rizzollo F, Rinaldi G, Zhang T, Teoh ST, Aurora AB, Karras P, Vermeire I, Broekaert D, Elsen JV, Knott MML, Orth MF, Demeyer S, Eelen G, Dobrolecki LE, Bassez A, Brussel TV, Sotlar K, Lewis MT, Bartsch H, Wuhrer M, Veelen PV, Carmeliet P, Cools J, Morrison SJ, Marine JC, Lambrechts D, Mazzone M, Hannon GJ, Lunt SY, Grünewald TGP, Park M, Rheenen JV, Fendt SM.
Rossi M, et al.
Nature. 2022 May;605(7911):747-753. doi: 10.1038/s41586-022-04758-2. Epub 2022 May 18.
Nature. 2022.
PMID: 35585241
Free PMC article.
In mice, circulating tumour cells and early metastatic lesions are enriched with Phgdh(low) cancer cells, and silencing Phgdh in primary tumours increases metastasis formation. ...Inhibition of sialylation counteracts the metastatic ability of Phgdh(low) canc …
In mice, circulating tumour cells and early metastatic lesions are enriched with Phgdh(low) cancer cells, and silencing Phgdh …